2233543-49-0

2233543-49-0 structure
2233543-49-0 structure
  • Name: GEM-5
  • Chemical Name: GEM-5
  • CAS Number: 2233543-49-0
  • Molecular Formula: C32H29F2N5O8
  • Molecular Weight: 649.60
  • Catalog: Signaling Pathways Apoptosis Apoptosis
  • Create Date: 2022-07-01 20:36:32
  • Modify Date: 2025-08-24 20:25:27
  • GEM-5 is a gemcitabine-based conjugate containing a HIF-1α inhibitor (YC-1) (IC50=30 nM). GEM-5 can significantly down-regulate the expression of HIF-1α and up-regulate the expression of tumor suppressor p53. GEM-5 induces the apoptosis of A2780 cells and inhibits tumor growth[1].

Name GEM-5
Description GEM-5 is a gemcitabine-based conjugate containing a HIF-1α inhibitor (YC-1) (IC50=30 nM). GEM-5 can significantly down-regulate the expression of HIF-1α and up-regulate the expression of tumor suppressor p53. GEM-5 induces the apoptosis of A2780 cells and inhibits tumor growth[1].
Related Catalog
Target

IC50: 30 nM (HIF-1α) in A2780[1]

In Vitro GEM-5 (0-80 μM; 12 hours) exhibits excellent antitumor activity toward A2780 cells under hypoxic condition with IC50 of 0.03 μM[1]. GEM-5 (0.5 μM; 72 hours) rises the apoptotic population to 52.67% under normoxic condition and 80.89% in A2780 cells under hypoxic condition[1]. GEM-5 (0.5 μM; 24 hours) arrests the cell cycle at the S phase (63.02% under normoxia and 72.64% under hypoxia)[1]. GEM-5 (0.1 and 1 μM; 24 hours) decreases the levels of HIF-1α and increases the levels of p53 in a dose dependent manner under hypoxic condition[1]. Apoptosis Analysis Cell Line: A2780 cells[1] Concentration: 0.5 μM Incubation Time: 72 hours Result: Rose the apoptotic population to 52.67% under normoxic condition and 80.89% under hypoxic condition. Cell Cycle Analysis Cell Line: A2780 cells[1] Concentration: 0.5 μM Incubation Time: 24 hours Result: Arrested the cell cycle at the S phase (63.02% under normoxia and 72.64% under hypoxia). Western Blot Analysis Cell Line: A2780 cells[1] Concentration: 0.1 and 1 μM Incubation Time: 24 hours Result: Decreased the levels of HIF-1α and increased the levels of p53 in a dose dependent manner
In Vivo GEM-5 (125 or 271 mg/kg; tail vein injection, once a week for 4 weeks) effectively inhibits tumor growth in the A2780 xenograft mouse model and exhibited low toxicity[1]. Animal Model: GEM-5 (125 or 271 mg/kg; tail vein injection, once a week for 4 weeks) effectively inhibits tumor growth in the A2780 xenograft mouse model and exhibited low toxicity[1]. Dosage: 125 or 271 mg/kg Administration: Tail vein injection, once a week for 4 weeks Result: Effectively inhibited tumor growth in the A2780 xenograft mouse model and exhibited low toxicity.
References

[1]. Xu Z, et al. A gemcitabine-based conjugate with enhanced antitumor efficacy by suppressing HIF-1α expression under hypoxia. Bioorg Med Chem. 2021;41:116214.

Molecular Formula C32H29F2N5O8
Molecular Weight 649.60
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.